BLISSGVS logo

Bliss GVS Pharma LTD

BLISSGVS·NSE·
625.15 +8.40 (+1.36%)
Market Cap6568.87 Cr
PE Ratio51.20
Volume4,02,269
Day High - Low635.00 - 601.00
52W High-Low635.00 - 118.00
DocStoX Score
5.6/10
Fair
Fair Value
Sign in to see
ROE
11.80%
Average
P/E
51.20x
Expensive
Debt / Equity
0.01
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed

Price performance

Day601.00
635.00
52W118.00
635.00
DocStoX take

Supported by risk (8.4) and momentum (7.5), but held back by valuation (0.0). Risk looks strong at 8.4, but that is offset by valuation at 0.0. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
5.6
/10
Fair
Quality
Solid
ROE 11.8%
Valuation
Expensive
P/E 51.2×
Growth
Steady
Revenue +9.9% 5Y CAGR
Risk
Low risk
D/E 0.01
Momentum
Strong
98% of 52-week range

At a glance

Market Cap
₹6,569 Cr
52W High / Low
₹635 / ₹118
Dividend Yield
0.27%
Promoter Holding
35.01%
EPS (TTM)
₹12.21
Book Value
₹113.00

Key highlights

  • Low leverage — D/E 0.01
  • Profitable in all of the last 5 years
  • Valuation is weak (0.0/10)
2 Positives1 Watchout

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

BLISS GVS PHARMA LTD peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.